Jefferson Antonio Buendia (Jefferson A Buendía, Jefferson A Buendía, Jefferson A Buendia, Jefferson Antonio Buendía, Jefferson Antonio Buendía, Buendía Jefferson Antonio)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 67

Top Venues

Pediatric pulmonology

The Journal of asthma : official journal of the Association for the Care of Asthma

F1000Research

Cost effectiveness and resource allocation : C/E

Universidad de Antioquia Facultad de Medicina

Universidad de Buenos Aires (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Antioquia Facultad de Medicina Feb 01 2012

Colombia

Professor :: Pharmacology and Toxicology

Education History

Universidad de Buenos Aires Feb 01 2010 - Mar 28 2015

Argentina

PHD :: Faculty of Pharmacy and Biochemistry

Universidad de La Frontera Jul 01 2009 - Jul 16 2012

Chile

MSC :: Faculty of Medicine

Publications

Jefferson Antonio Buendia, Andrés Felipe Zuluaga Salazar
Is there an association between TLR 4 Asp 299Gly and severe RSV infection? Systematic review and metanalysis. Pediatric pulmonology (2024)
Jefferson Antonio Buendia, Andrés Felipe Zuluaga Salazar
Is there an association between TLR 4 Asp 299Gly and severe RSV infection? Systematic review and metanalysis. Pediatric pulmonology 59 (7) (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Andrés Felipe Zuluaga Salazar
Continuous positive airway pressure in children under 6 years with severe acute lower respiratory infections: Systematic review and metanalysis. Pediatric pulmonology 59 (6) (2024)
Jefferson Antonio Buendia, Ranniery Acuña-Cordero, Carlos E Rodriguez-Martinez
Exploratory analysis of the economically justifiable price of nirsevimab for healthy late-preterm and term infants in Colombia. Pediatric pulmonology (2024)
Jefferson Antonio Buendia, Andrés Felipe Zuluaga Salazar
Genotype-driven asthma prescribing of inhaled corticosteroids and long-acting β2-agonist: A cost-effectiveness analysis. Pediatric pulmonology (2024)
Jefferson Antonio Buendia, Andrés Felipe Zuluaga Salazar
Efficient use of mepolizumab in children: An analysis of the economically justifiable price in Colombia. Pediatric pulmonology (2024)
Jefferson Antonio Buendia, Diana Guerrero-Patino, Andres Zuluaga
Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates. The Journal of asthma : official journal of the Association for the Care of Asthma (2024)
Jefferson Antonio Buendia, Diana Guerrero-Patino, Andres Zuluaga
Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates. The Journal of asthma : official journal of the Association for the Care of Asthma 61 (9) (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Andrés Felipe Zuluaga Salazar
Continuous positive airway pressure in children under 6 years with severe acute lower respiratory infections: Systematic review and metanalysis. Pediatric pulmonology 59 (6) (2024)
Jefferson Antonio Buendia, Andrés Felipe Zuluaga Salazar
Is there an association between TLR 4 Asp 299Gly and severe RSV infection? Systematic review and metanalysis. Pediatric pulmonology 59 (7) (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Andrés Felipe Zuluaga Salazar
Continuous positive airway pressure in children under 6 years with severe acute lower respiratory infections: Systematic review and metanalysis. Pediatric pulmonology (2024)
Jefferson Antonio Buendia, Ranniery Acuña-Cordero, Carlos E Rodriguez-Martinez
Exploratory analysis of the economically justifiable price of nirsevimab for healthy late-preterm and term infants in Colombia. Pediatric pulmonology 59 (5) (2024)
Jefferson Antonio Buendia, Diana Guerrero-Patino, Andres Zuluaga
Cost-Utility Analysis of Prenatal Supplementation with Long-Chain n-3 Fatty Acids to Reduce the Incidence of Wheezing and Asthma in Neonates. The Journal of asthma : official journal of the Association for the Care of Asthma (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Cost-utility of tiotropium in patients with severe asthma. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jefferson Antonio Buendia, Andrés Felipe Zuluaga Salazar
Is there an association between TLR 4 Asp 299Gly and severe RSV infection? Systematic review and metanalysis. Pediatric pulmonology 59 (7) (2024)
Jefferson Antonio Buendia, Ranniery Acuña-Cordero, Carlos E Rodriguez-Martinez
Exploratory analysis of the economically justifiable price of nirsevimab for healthy late-preterm and term infants in Colombia. Pediatric pulmonology 59 (5) (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Cost-utility of tiotropium in patients with severe asthma. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Andrés Felipe Zuluaga Salazar
Economic evidence supports the cost savings of sputum eosinophil counts to guide the treatment of pediatrics patients with persistent asthma: implications for clinical practice guidelines in middle-income countries. The Journal of asthma : official journal of the Association for the Care of Asthma 61 (7) (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Andrés Felipe Zuluaga Salazar
Cost effectiveness of omalizumab for severe asthma in Colombia. The Journal of asthma : official journal of the Association for the Care of Asthma (2023)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Erika Fernanda Lindarte
Vitamin D supplementation for children with mild to moderate asthma: an economic evaluation. The Journal of asthma : official journal of the Association for the Care of Asthma (2023)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Andrés Felipe ZuluagaSalazar
Economic Evidence Supports the Cost Savings of Sputum Eosinophil Counts to guide the treatment of pediatrics patients with Persistent Asthma: Implications for Clinical Practice Guidelines in Middle-Income Countries. The Journal of asthma : official journal of the Association for the Care of Asthma (2023)
Jefferson Antonio Buendia, Diana Guerrero Patino, Erika Fernanda Lindarte
Effectiveness of high-dose vitamin D supplementation to reduce the incidence rate of repeat episodes of pneumonia in children: A systematic review. Pediatric pulmonology (2023)
Jefferson Antonio Buendia, Diana G Patiño, Erika F Lindarte
Ambrisentan for in pediatric pulmonary arterial hypertension: A cost-utility analysis. Pediatric pulmonology (2023)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Andrés Felipe Zuluaga Salazar
Assessing the economic implications of impulse oscillometry in preschoolers with asthma in Colombia. Pediatric pulmonology (2023)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Erika Fernanda Lindarte
Vitamin D supplementation for children with mild to moderate asthma: an economic evaluation. The Journal of asthma : official journal of the Association for the Care of Asthma (2023)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Corticosteroids for the treatment of respiratory infection by Mycoplasma pneumoniae in children: A cost-utility analysis. Pediatric pulmonology (2023)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Andrés Felipe Zuluaga Salazar
Economic evidence supports the cost savings of sputum eosinophil counts to guide the treatment of pediatrics patients with persistent asthma: implications for clinical practice guidelines in middle-income countries. The Journal of asthma : official journal of the Association for the Care of Asthma (2023)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Erika Fernanda Lindarte
Ambrisentan for in pediatric pulmonary arterial hypertension: a cost-utility analysis. Pediatric pulmonology (2023)
Jefferson Antonio Buendia, Diana Guerrero Patino, Erika Fernanda Lindarte
Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension. Expert review of pharmacoeconomics & outcomes research (2023)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Tiotropium for children and adolescents with severe asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Jefferson Antonio Buendia, Ranniery Acuña-Cordero, Diana Guerrero Patiño
The role of high carbohydrate-rich food intake and severity of asthma exacerbation in children between 2 to 6 years aged. The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Juan Esteban Giraldo Ramírez
Cost Utility of Intermittent Inhaled Corticosteroids in Preschoolers with Viral-Triggered Wheeze. Pediatric allergy, immunology, and pulmonology 35 (1) (2022)
Jefferson Antonio Buendia, Erika Fernanda Lindarte, Diana Guerrero Patiño
Comparison of three alternatives for the management of moderate asthma in children aged 6-11 years: a cost-utility analysis. The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Erika Fernanda Lindarte
Vitamin A supplementation for the prevention of chronic lung disease in premature infants: A cost-utility analysis. Pediatric pulmonology 57 (10) (2022)
Carlos E Rodriguez-Martinez, Monica P Sossa-Briceño, Jefferson Antonio Buendia
Comparison of two oxygen saturation targets to decide on hospital discharge of infants with viral bronchiolitis living at high altitudes: a cost-effectiveness analysis. Current medical research and opinion 38 (12) (2022)
Jefferson Antonio Buendia, Diana G Patiño
Dupilumab in children with moderate-to-severe asthma: A cost utility analysis. Pediatric pulmonology 57 (10) (2022)
Jefferson Antonio Buendia, Marisela Bedoya, Dione Benjumea-Bedoya
Occult bacteraemia in children with fever without focus though previously vaccinated against pneumococcus. Tropical doctor 52 (4) (2022)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Fluticasone furoate plus vilanterol in patients with moderate persistent asthma: a cost-utility analysis. The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Jefferson Antonio Buendia, Carlos E Rodriguez-Martinez, Monica P Sossa-Briceño
Cost utility of vitamin D supplementation in adults with mild to moderate asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Jefferson Antonio Buendia, John E Feliciano-Alfonso, Ivan D Florez
Systematic review and cost-utility of high flow nasal cannula versus continuous positive airway pressure in children with acute severe or moderate bronchiolitis in Colombia. Pediatric pulmonology 57 (12) (2022)
Jefferson Antonio Buendia, Diana Guerrero Patino
Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis. F1000Research 10 (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Risk factors for severe bronchiolitis in Colombia. Tropical doctor 51 (3) (2021)
Jefferson Antonio Buendia, Diana Guerrero Patino
Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis. F1000Research 10 (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Hernan Lucio Talamoni
Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma. Pediatric pulmonology 56 (12) (2021)
Jefferson Antonio Buendia, Cristian Ramírez Velasquez, Dione Benjumea-Bedoya
Bronchopulmonary dysplasia: Incidence and severity in premature infants born at high altitude. Pediatric pulmonology (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño
SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis. The Journal of asthma : official journal of the Association for the Care of Asthma 59 (12) (2021)
Diana Guerrero-Patiño, Jefferson Antonio Buendia
Budget impact analysis of intravenous magnesium sulfate for treating asthma exacerbations in children. Pediatric pulmonology 56 (7) (2021)
Jefferson Antonio Buendia, John Edwin Feliciano-Alfonso
Inappropriate antibiotic prescribing for acute bronchiolitis in Colombia: a predictive model. Journal of pharmaceutical policy and practice 14 (1) (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective. BMC health services research 21 (1) (2021)
Jefferson Antonio Buendia, Diana Guerrero Patino
Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis. F1000Research 10 (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Yamith Eutimio Cossio-Giraldo
Cost‑effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2021)
Jefferson Antonio Buendia, Ranniery Acuña-Cordero, Carlos E Rodriguez-Martinez
The cost-utility of early use of high-flow nasal cannula in bronchiolitis. Health economics review 11 (1) (2021)
Jefferson Antonio Buendia, Carlos E Rodriguez-Martinez, Monica P Sossa-Briceño
Cost-utility of tiotropium for children with severe asthma in patients aged 1-5 years. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 32 (8) (2021)
Carlos E Rodriguez-Martinez, Monica P Sossa-Briceño, Jefferson Antonio Buendia
The use of ipratropium bromide for treating moderate to severe asthma exacerbations in pediatric patients in an emergency setting: A cost-effectiveness analysis. Pediatric pulmonology 56 (12) (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia. Expert review of pharmacoeconomics & outcomes research (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño, John Edwin Feliciano-Alfonso
Cost-utility of azithromycin in patients with severe asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2021)
Jefferson Antonio Buendia, Ranniery Acuña-Cordero, Carlos E Rodriguez-Martinez
Budget impact analysis of high-flow nasal cannula for infant bronchiolitis: the Colombian National Health System perspective. Current medical research and opinion 37 (9) (2021)
Jefferson Antonio Buendia, Diana Guerrero Patino
Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis. F1000Research 10 (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño, Melisa Lopez Moreno
Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia. Expert review of pharmacoeconomics & outcomes research (2021)
Jefferson Antonio Buendia, Ranniery Acuña-Cordero, Carlos E Rodriguez-Martinez
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma. Cost effectiveness and resource allocation : C/E 19 (1) (2021)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Costs of Respiratory Syncytial Virus Hospitalizations in Colombia. PharmacoEconomics - open (2020)
Jefferson Antonio Buendia, Ranniery Acuña-Cordero, Carlos E Rodriguez-Martinez
The cost-utility of intravenous magnesium sulfate for treating asthma exacerbations in children. Pediatric pulmonology 55 (10) (2020)
Carlos E Rodriguez-Martinez, Gustavo Nino, Jose A Castro-Rodriguez, Geovanny F Perez, Monica P Sossa-Briceño, Jefferson Antonio Buendia
Cost-effectiveness analysis of phenotypic-guided versus guidelines-guided bronchodilator therapy in viral bronchiolitis. Pediatric pulmonology 56 (1) (2020)
Jefferson Antonio Buendia, Esteban Halac, Andrea Bosaleh, María T Garcia de Davila, Oscar Imvertasa, Guillermo Bramuglia
Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation. Pharmaceutics 12 (9) (2020)
Jefferson Antonio Buendia, Hernan Lucio Talamoni
Cost-utility of use of sputum eosinophil counts to guide management in children with asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2020)
Jefferson Antonio Buendia, José Armando Justinico Castro, Laura Joanna Tapia Vela, Denis Sinisterra, Juana Patricia Sánchez Villamil, Andrés Felipe Zuluaga Salazar
Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage. BMC research notes 12 (1) (2019)
Jefferson Antonio Buendia, Gabriel Jaime Restrepo Chavarriaga, Andrés F Zuluaga
Burden of paraquat poisoning in the department of Antioquia, Colombia. BMC pharmacology & toxicology 20 (1) (2019)

Jefferson Antonio Buendia.css-eqlu8i{font-size:small;padding-left:4px;} (Jefferson A Buendía, Jefferson A Buendía, Jefferson A Buendia, Jefferson Antonio Buendía, Jefferson Antonio Buendía, Buendía Jefferson Antonio)

Publication Activity (10 Years)

Top Topics

Top Venues

Jefferson Antonio Buendia (Jefferson A Buendía, Jefferson A Buendía, Jefferson A Buendia, Jefferson Antonio Buendía, Jefferson Antonio Buendía, Buendía Jefferson Antonio)